Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Pietro A. Mastrangelo"'
Autor:
Rosj Gallicchio, Pietro A. Mastrangelo, Antonio Prospero Colasurdo, Matteo Landriscina, Anna Nardelli, Giuseppe Guglielmi, Pier Paolo Mainenti, Giovanni Storto
Publikováno v:
Tumori. 105(5)
Radium-223 dichloride (223Ra) is the first, recently approved, α-particle-emitting radiopharmaceutical for the treatment of patients with bone metastases in castration-resistant prostate cancer (CRPC) and no evidence of visceral metastases. We explo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdefdc9a5357231627d5f8febc422641
https://pubmed.ncbi.nlm.nih.gov/31096849
https://pubmed.ncbi.nlm.nih.gov/31096849
Autor:
Paola Rabasco, Vittorio Simeon, Antonella Lotumolo, Giuseppe Guglielmi, Luciana Rago, Aldo Cammarota, Luca Macarini, Pietro A. Mastrangelo, Antonio Villonio, Rocchina Caivano, Matilde Gioioso, Valeria Panebianco, Giancarlo Iannelli, Flavio Barchetti
Publikováno v:
Tumori Journal. 102:71-76
Aims To evaluate the utility of a multiparametric 3T magnetic resonance imaging (MRI) study using diffusion-weighted images (DWI) for the assessment of prostate cancer before and after radiotherapy (RT). Methods A total of 34 patients, who received a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fecc19ce010f48087f01f88f9fb7b5d
https://doi.org/10.5301/tj.5000415
https://doi.org/10.5301/tj.5000415